Mainz Biomed B.V. announced the appointment of Darin Leigh as Chief Commercial Officer. Darin comes to the role with over 25 years of product lifecycle management and global commercial operations experience across Europe, the United States and Asia.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.855 USD | -4.86% | -3.81% | -25.03% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.03% | 19.67M | |
-16.65% | 8.34B | |
+39.52% | 3.59B | |
-32.64% | 2.75B | |
-8.06% | 2.48B | |
-9.58% | 2.32B | |
-14.09% | 1.79B | |
-19.18% | 1.54B | |
-40.19% | 1.21B | |
+5.57% | 1.13B |
- Stock Market
- Equities
- MYNZ Stock
- News Mainz Biomed N.V.
- Mainz Biomed Appoints Darin Leigh as Chief Commercial Officer